These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10497006)

  • 1. Passive antibody therapies: progress and continuing challenges.
    Casadevall A
    Clin Immunol; 1999 Oct; 93(1):5-15. PubMed ID: 10497006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive antibody therapy for infectious diseases.
    Casadevall A; Dadachova E; Pirofski LA
    Nat Rev Microbiol; 2004 Sep; 2(9):695-703. PubMed ID: 15372080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-based therapeutics: focus on prostate cancer.
    Ross JS; Gray KE; Webb IJ; Gray GS; Rolfe M; Schenkein DP; Nanus DM; Millowsky MI; Bander NH
    Cancer Metastasis Rev; 2005 Dec; 24(4):521-37. PubMed ID: 16408160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific antibodies for dual-modality cancer therapy: killing two signaling cascades with one stone.
    Marvin JS; Zhu Z
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):184-93. PubMed ID: 16566289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody therapy for prostate cancer.
    Jakobovits A
    Handb Exp Pharmacol; 2008; (181):237-56. PubMed ID: 18071949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools.
    Lichtlen P; Mohajeri MH
    J Neurochem; 2008 Feb; 104(4):859-74. PubMed ID: 17986215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of antibodies into versatile tumor-targeting agents.
    Lin MZ; Teitell MA; Schiller GJ
    Clin Cancer Res; 2005 Jan; 11(1):129-38. PubMed ID: 15671537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in MS therapeutics: vehicles of hope.
    Fox RJ; Ransohoff RM
    Trends Immunol; 2004 Dec; 25(12):632-6. PubMed ID: 15530830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody production: polyclonal-derived biotherapeutics.
    Newcombe C; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):2-7. PubMed ID: 16893686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Therapy of Cancer--fifth symposium. From basic research to clinical application. 27-30 October 1999, Munich, Germany.
    Francis R; Chao D
    IDrugs; 2000 Feb; 3(2):142-6. PubMed ID: 16107923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.